UCDCC#272: IL-2, Radiotherapy, and Pembrolizumab in Patients Refractory to Checkpoint Blockade
University of California, Davis
University of California, Davis
Providence Health & Services
Stanford University
Stanford University
Alliance for Clinical Trials in Oncology
NYU Langone Health
University of Utah
Alliance for Clinical Trials in Oncology
National Institutes of Health Clinical Center (CC)